000 01695 a2200541 4500
005 20250510212800.0
264 0 _c19760803
008 197608s 0 0 eng d
022 _a0307-6938
024 7 _a10.1111/j.1365-2230.1976.tb01393.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCunliffe, W J
245 0 0 _aDowling oration 1975. Fibrinolysis and vasculitis.
_h[electronic resource]
260 _bClinical and experimental dermatology
_cMar 1976
300 _a1-16 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Topical
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnabolic Agents
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aChronic Disease
650 0 4 _aEndothelium
_xpathology
650 0 4 _aEthylestrenol
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFibrin
_xanalysis
650 0 4 _aFibrinolysin
_xanalysis
650 0 4 _aFibrinolysis
_xdrug effects
650 0 4 _aFollow-Up Studies
650 0 4 _aHistocytochemistry
650 0 4 _aHumans
650 0 4 _aInflammation
_xblood
650 0 4 _aLeg Ulcer
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhenformin
_xtherapeutic use
650 0 4 _aPurpura
_xblood
650 0 4 _aRats
650 0 4 _aSkin Diseases
_xdrug therapy
650 0 4 _aThrombophlebitis
_xblood
650 0 4 _aVascular Diseases
_xblood
650 0 4 _aWound Healing
773 0 _tClinical and experimental dermatology
_gvol. 1
_gno. 1
_gp. 1-16
856 4 0 _uhttps://doi.org/10.1111/j.1365-2230.1976.tb01393.x
_zAvailable from publisher's website
999 _c129311
_d129311